HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The value of lipopolysaccharide binding protein for diagnosis of late-onset neonatal sepsis in very low birth weight infants.

AbstractOBJECTIVE:
To assess the accuracy of lipopolysaccharide binding protein (LBP) for diagnosing late-onset neonatal sepsis (LONS) in very low birth weight (VLBW) infants.
STUDY DESIGN:
Observational, prospective study. We assessed the diagnostic performance of LBP in 26 suspected LONS episodes among 54 patients. Proven and probable LONS episodes were recorded according to established criteria. Receiver operating characteristic curve analysis was performed to evaluate LBP's ability to predict LONS.
RESULTS:
LONS was diagnosed in 17 of 26 episodes. LBP levels were significantly higher in confirmed LONS episodes (P<0.001). The area under the curve of LBP was 0.89. A cut-off of 17.5 μg/mL had a sensitivity of 94.1%, a specificity of 77.8%, a positive predictive value of 88.9% and a negative predictive value of 87.5%.
CONCLUSIONS:
Serum LBP measurement may be useful as an additional tool in the evaluation of suspected LONS in VLBW infants.
AuthorsJosé Luis Leante-Castellanos, Luis García de Guadiana-Romualdo, Carmen Fuentes-Gutiérrez, Ana Hernando-Holgado, Ana García-González, Enrique Jiménez-Santos
JournalJournal of perinatal medicine (J Perinat Med) Vol. 43 Issue 2 Pg. 253-7 (Mar 2015) ISSN: 1619-3997 [Electronic] Germany
PMID25014514 (Publication Type: Journal Article, Observational Study)
Chemical References
  • Acute-Phase Proteins
  • Carrier Proteins
  • Membrane Glycoproteins
  • lipopolysaccharide-binding protein
Topics
  • Acute-Phase Proteins
  • Carrier Proteins (blood)
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Very Low Birth Weight (blood)
  • Male
  • Membrane Glycoproteins (blood)
  • Prospective Studies
  • Reference Values
  • Sepsis (blood, diagnosis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: